Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × UNKNOWN × nabiximols × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Withdrawn 1 Terminated 1

Sponsor Class

UNKNOWN 2 OTHER_GOV 1 OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Advanced Cancer 1

Interventions

nabiximols 2 icaritin 2 Capecitabine 2 pembrolizumab 1 S 1 (combination) 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Oxaliplatin 1 Drug Therapy 1 Chlorogenic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01975688 2016-08-11

A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis

GWPharm

Phase 1 Terminated

Squamous Cell Carcinoma of Head and Neck

NCT02432612 2016-03-02

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

GWPharm

Phase 1 Withdrawn

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡